Prodose develops and manufactures private-label OTC and nutraceutical products, pairing bulk production in India with final packaging and distribution from its 106,000-square-foot facility in Ronkonkoma, New York. Its vertically integrated model is backed by Softgel Healthcare Pvt. Ltd., which produces more than 2 billion softgels annually, while Prodose’s U.S. team handles formulation, regulatory work, packaging, and logistics. The company is particularly distinctive for its proprietary Gummesules gummy-softgel technology and its focus on taking health products from concept to retail shelf.
WHO-GMP
US FDA approval
EU-GMP
NSF
TGA
INVIMA
Health Canada
ANVISA
21 CFR Part 11
Compliance program
21 CFR
Compliance program
SMETA 4-Pillar
Compliance program
FDA-registered facility
Registration
cGMP/GMP
Compliance program
FDA
Quality certification
GMP
Quality certification